サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1279800

結核（TB）診断の世界市場規模調査＆予測、診断別、検査タイプ別、エンドユーザー別、地域別分析、2022-2029年

Global Tuberculosis Diagnostics Market Size study & Forecast, by Diagnostics Test Type, by End-User, and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
結核（TB）診断の世界市場規模調査＆予測、診断別、検査タイプ別、エンドユーザー別、地域別分析、2022-2029年
出版日: 2023年05月15日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

結核は、結核菌によって引き起こされる伝染性の感染症です。

主に肺に感染しますが、腎臓、脊椎、脳など体の他の部位に感染することもあります。結核は、感染者の咳、くしゃみ、会話によって空気中に広がり、他の人がその細菌を吸い込むことで感染します。結核診断市場は、結核の発生率の増加、政府の支援策、官民連携の強化などの要因によって拡大しています。

市場拡大を後押しする主な要因は、結核や多剤耐性結核（MDR-TB）の症例数の増加です。例えば、世界保健機関（WHO）の「Global Tuberculosis Report 2021」によると、2021年10月、結核患者の大半は東南アジア（43％）、アフリカ（25％）、西太平洋（18％）で発見され、東地中海（8.3%）、欧州（2.3%）で発見された患者は少なかっています。また、世界保健機関（WHO）が発表した統計によると、2020年には世界で約1000万人が結核に感染し、2021年10月には約150万人が結核が原因で死亡するとされています。そのため、国民の間で結核の有病率が高まることで、より優れた診断ツールや治療法への需要が高まり、予測期間中の市場拡大が期待されています。さらに、先進的な検査方法の登場は、市場に有利な成長をもたらしています。しかし、結核診断薬のコストが高く、既存の結核診断薬には限界があるため、市場の成長を阻害する可能性があります。

結核診断薬の世界市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他世界の地域です。北米は、地域における結核患者の増加、高度なヘルスケアシステムの利用、高い医療費などの要因により、収益面で市場を独占しています。一方、アジア太平洋は、対象疾患の有病率の上昇、政府の取り組みの高まり、新技術の開発の高まりなどの要因により、予測期間中に最も高いCAGRで成長すると予想されます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や診断、検査タイプなどの詳細な分析とともに、関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界・セグメント別市場推計・予測、2019年～2029年
    • 結核（TB）診断市場、地域別、2019年-2029年
    • 結核（TB）診断市場：診断テストタイプ別、2019年-2029年
    • 結核（TB）診断市場：エンドユーザー別、2019年～2029年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 結核（TB）診断薬の世界市場定義とスコープ

  • 本調査の目的
  • 市場の定義とスコープ
    • 本調査の対象範囲
    • 産業の進化
  • 調査対象年
  • 通貨換算レート

第3章 結核（TB）診断の世界市場力学

  • 結核（TB）診断市場のインパクト分析（2019年～2029年）
    • 市場促進要因
      • 結核の罹患率の増加
      • 政府の支援的な取り組み
      • 官民パートナーシップの増加
    • 市場の課題
      • 結核診断薬のコスト高
      • 既存の結核診断薬の限界
    • 市場参入の可能性
      • 先進的な検査法の登場

第4章 結核診断薬の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルの未来的アプローチ（2019年～2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • トップ投資機会
  • 主要成功戦略
  • 業界専門家別展望
  • アナリストの結論・提言

第5章 リスクアセスメントCOVID-19のインパクト

  • COVID-19が業界に与える全体的な影響についてのアセスメント
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 結核診断薬の世界市場：診断薬テストタイプ別

  • 市場スナップショット
  • 結核診断薬の世界市場：診断検査タイプ別、性能-ポテンシャル分析
  • 結核（TB）診断薬の世界市場、診断検査タイプ別推定・予測2019-2029
  • 結核（TB）診断市場、サブセグメント別分析
    • レントゲン検査
    • ラボラトリー検査
    • 核酸検査（Nucleic Acid Testing
    • サイトカイン検出検査
    • その他の診断テストタイプ

第7章 結核診断薬の世界市場：エンドユーザー別

  • 市場スナップショット
  • 結核診断薬の世界市場：エンドユーザー別、性能-ポテンシャル分析
  • 結核（TB）診断の世界市場エンドユーザー別推定・予測2019-2029
  • 結核（TB）診断市場、サブセグメント別分析
    • 病院/診療所
    • 診断/調査研究所
    • その他のエンドユーザー

第8章 結核（TB）診断の世界市場：地域別分析

  • 結核診断市場、地域別市場スナップショット
  • 北米
    • 米国
      • 診断検査タイプ別の推定・予測、2019年～2029年
      • エンドユーザー別の推定・予測、2019年～2029年
    • カナダ
  • 欧州結核診断市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域の結核診断市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの結核診断市場スナップショット
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 世界のその他の地域

第9章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Abbott Laboratories
      • 主要情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • Becton, Dickinson and Company
    • BioMerieux SA
    • Cepheid
    • F. Hoffmann-La Roche AG
    • Hain Lifescience GmbH
    • Hologic Corporation
    • Qiagen
    • AdvaCare Pharma
    • Thermo Fisher Scientific Inc.

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Tuberculosis (TB) Diagnostics Market, report scope
  • TABLE 2. Global Tuberculosis (TB) Diagnostics Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Tuberculosis (TB) Diagnostics Market estimates & forecasts by Diagnostic Test Type 2019-2029 (USD Billion)
  • TABLE 4. Global Tuberculosis (TB) Diagnostics Market estimates & forecasts by End-User 2019-2029 (USD Billion)
  • TABLE 5. Global Tuberculosis (TB) Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Tuberculosis (TB) Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Tuberculosis (TB) Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Tuberculosis (TB) Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Tuberculosis (TB) Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Tuberculosis (TB) Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Tuberculosis (TB) Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Tuberculosis (TB) Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Tuberculosis (TB) Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Tuberculosis (TB) Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Tuberculosis (TB) Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Tuberculosis (TB) Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Tuberculosis (TB) Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Tuberculosis (TB) Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Tuberculosis (TB) Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Tuberculosis (TB) Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Tuberculosis (TB) Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Tuberculosis (TB) Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Tuberculosis (TB) Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Tuberculosis (TB) Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Tuberculosis (TB) Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Tuberculosis (TB) Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Tuberculosis (TB) Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Tuberculosis (TB) Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Tuberculosis (TB) Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Tuberculosis (TB) Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Tuberculosis (TB) Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Tuberculosis (TB) Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Tuberculosis (TB) Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Tuberculosis (TB) Diagnostics Market
  • TABLE 70. List of primary sources, used in the study of global Tuberculosis (TB) Diagnostics Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Tuberculosis (TB) Diagnostics Market, research methodology
  • FIG 2. Global Tuberculosis (TB) Diagnostics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Tuberculosis (TB) Diagnostics Market, key trends 2021
  • FIG 5. Global Tuberculosis (TB) Diagnostics Market, growth prospects 2022-2029
  • FIG 6. Global Tuberculosis (TB) Diagnostics Market, porters 5 force model
  • FIG 7. Global Tuberculosis (TB) Diagnostics Market, pest analysis
  • FIG 8. Global Tuberculosis (TB) Diagnostics Market, value chain analysis
  • FIG 9. Global Tuberculosis (TB) Diagnostics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Tuberculosis (TB) Diagnostics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Tuberculosis (TB) Diagnostics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Tuberculosis (TB) Diagnostics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Tuberculosis (TB) Diagnostics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Tuberculosis (TB) Diagnostics Market, regional snapshot 2019 & 2029
  • FIG 15. North America Tuberculosis (TB) Diagnostics Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Tuberculosis (TB) Diagnostics Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia Pacific Tuberculosis (TB) Diagnostics Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Tuberculosis (TB) Diagnostics Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Tuberculosis (TB) Diagnostics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Tuberculosis (TB) Diagnostics Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029.Tuberculosis (TB) is a contagious infectious disease caused by the bacterium Mycobacterium tuberculosis. It primarily affects the lungs but can also affect other parts of the body, such as the kidneys, spine, and brain. TB is spread through the air when an infected person coughs, sneezes, or talks, and others inhale the bacteria.. The Tuberculosis (TB) Diagnostics market is expanding because of factors such as increasing incidence of Tuberculosis, supportive government initiatives and increased Public-Private Partnerships.

The primary driver fueling market expansion is the increase in cases of tuberculosis and multi-drug resistant tuberculosis (MDR-TB). For instance, the World Health Organization's (WHO) Global Tuberculosis Report 2021 states that in October 2021, the majority of tuberculosis cases were discovered in South-East Asia (43%), Africa (25%), and the Western Pacific (18%), while fewer cases were discovered in the Eastern Mediterranean (8.3%), and Europe (2.3%). Additionally, according to statistics released by the World Health Organization (WHO), around 10 million individuals worldwide contracted tuberculosis in 2020, and roughly 1.5 million people died as a result of the disease in October 2021. Therefore, the increased prevalence of tuberculosis among the population drives up the demand for better diagnostic tools and therapies, which is expected to drive market expansion over the forecast period. Furthermore, advent of advanced test methods is creating lucrative growth in the market. However, high cost of tuberculosis (tb) diagnostics and limitations of existing tuberculosis (TB) diagnostics may halt market growth.

The key regions considered for the Global Tuberculosis (TB) Diagnostics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to factors such as increasing number of cases of tuberculosis in the area, the availability of an advanced healthcare system, and high healthcare spending. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising prevalence of target disease, rising government initiatives, and rising development of new technology.

Major market players included in this report are:

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • BioMerieux SA
  • Cepheid
  • F. Hoffmann-La Roche AG
  • Hain Lifescience GmbH
  • Hologic Corporation
  • Qiagen
  • AdvaCare Pharma
  • Thermo Fisher Scientific Inc.

Recent Developments in the Market:

  • In February 2022, SRL Diagnostics announced the launch of a whole genome sequencing test for tuberculosis The test shortens the time needed to identify multi-drug resistant tuberculosis and provides a comprehensive resistance profile to 18 different anti-TB medications.
  • Thermo Fisher Scientific Inc. introduced the SeqStudio Flex Series Genetic Analyzer, For research and development of infectious disease detection. which is anticipated to broaden the company's product line in the market.

Global Tuberculosis (TB) Diagnostics Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Diagnostic Test Type, End-User, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Diagonistics Test Typeofferings of key players. The detailed segments and sub-segment of the market are explained below.

By Diagnostic Test Type:

  • Radiographic Test
  • Laboratory Test
  • Nucleic Acid Testing
  • Cytokine Detection Test
  • Other Diagnostic Test Types

By End-User:

  • Human Tuberculosis (TB) Diagnostics
  • Tuberculosis (TB) Diagnostics Analog

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Tuberculosis (TB) Diagnostics Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Tuberculosis (TB) Diagnostics Market, by Diagnostic Test Type, 2019-2029 (USD Billion)
    • 1.2.3. Tuberculosis (TB) Diagnostics Market, by End-User, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Tuberculosis (TB) Diagnostics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Tuberculosis (TB) Diagnostics Market Dynamics

  • 3.1. Tuberculosis (TB) Diagnostics Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of Tuberculosis
      • 3.1.1.2. Supportive government initiatives
      • 3.1.1.3. Increased Public-Private Partnerships
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Tuberculosis (TB) Diagnostics
      • 3.1.2.2. Limitations of Existing Tuberculosis (TB) Diagnostics
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advent of advanced test methods

Chapter 4. Global Tuberculosis (TB) Diagnostics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Tuberculosis (TB) Diagnostics Market, by Diagnostics Test Type

  • 6.1. Market Snapshot
  • 6.2. Global Tuberculosis (TB) Diagnostics Market by Diagnostic Test Type, Performance - Potential Analysis
  • 6.3. Global Tuberculosis (TB) Diagnostics Market Estimates & Forecasts by Diagnostic Test Type 2019-2029 (USD Billion)
  • 6.4. Tuberculosis (TB) Diagnostics Market, Sub Segment Analysis
    • 6.4.1. Radiographic Test
    • 6.4.2. Laboratory Test
    • 6.4.3. Nucleic Acid Testing
    • 6.4.4. Cytokine Detection Test
    • 6.4.5. Other Diagnostic Test Types

Chapter 7. Global Tuberculosis (TB) Diagnostics Market, by End-User

  • 7.1. Market Snapshot
  • 7.2. Global Tuberculosis (TB) Diagnostics Market by End-User, Performance - Potential Analysis
  • 7.3. Global Tuberculosis (TB) Diagnostics Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
  • 7.4. Tuberculosis (TB) Diagnostics Market, Sub Segment Analysis
    • 7.4.1. Hospitals/Clinics
    • 7.4.2. Diagnostics/Research Laboratory
    • 7.4.3. Other End-Users

Chapter 8. Global Tuberculosis (TB) Diagnostics Market, Regional Analysis

  • 8.1. Tuberculosis (TB) Diagnostics Market, Regional Market Snapshot
  • 8.2. North America Tuberculosis (TB) Diagnostics Market
    • 8.2.1. U.S. Tuberculosis (TB) Diagnostics Market
      • 8.2.1.1. Diagnostic Test Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. End-User breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Tuberculosis (TB) Diagnostics Market
  • 8.3. Europe Tuberculosis (TB) Diagnostics Market Snapshot
    • 8.3.1. U.K. Tuberculosis (TB) Diagnostics Market
    • 8.3.2. Germany Tuberculosis (TB) Diagnostics Market
    • 8.3.3. France Tuberculosis (TB) Diagnostics Market
    • 8.3.4. Spain Tuberculosis (TB) Diagnostics Market
    • 8.3.5. Italy Tuberculosis (TB) Diagnostics Market
    • 8.3.6. Rest of Europe Tuberculosis (TB) Diagnostics Market
  • 8.4. Asia-Pacific Tuberculosis (TB) Diagnostics Market Snapshot
    • 8.4.1. China Tuberculosis (TB) Diagnostics Market
    • 8.4.2. India Tuberculosis (TB) Diagnostics Market
    • 8.4.3. Japan Tuberculosis (TB) Diagnostics Market
    • 8.4.4. Australia Tuberculosis (TB) Diagnostics Market
    • 8.4.5. South Korea Tuberculosis (TB) Diagnostics Market
    • 8.4.6. Rest of Asia Pacific Tuberculosis (TB) Diagnostics Market
  • 8.5. Latin America Tuberculosis (TB) Diagnostics Market Snapshot
    • 8.5.1. Brazil Tuberculosis (TB) Diagnostics Market
    • 8.5.2. Mexico Tuberculosis (TB) Diagnostics Market
    • 8.5.3. Rest of Latin America Tuberculosis (TB) Diagnostics Market
  • 8.6. Rest of The World Tuberculosis (TB) Diagnostics Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Abbott Laboratories
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Becton, Dickinson and Company
    • 9.2.3. BioMerieux SA
    • 9.2.4. Cepheid
    • 9.2.5. F. Hoffmann-La Roche AG
    • 9.2.6. Hain Lifescience GmbH
    • 9.2.7. Hologic Corporation
    • 9.2.8. Qiagen
    • 9.2.9. AdvaCare Pharma
    • 9.2.10. Thermo Fisher Scientific Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption